{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:53:03Z","timestamp":1792464783742,"version":"4.5.0"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Sj\u00f6gren\u2019s syndrome (SjS) is a heterogeneous systemic disease. The abnormal responses to La\/SSB and Ro\/SSA of both B-cells and T-cells are implicated as well as others, in the destruction of the epithelium of the exocrine glands, whose tissue characteristically shows a peri-epithelial lymphocytic infiltration that can vary from sicca syndrome to systemic disease and lymphoma. Despite the appearance of new autoantibodies, anti-Ro\/SSA is still the only autoantibody included in the American College of Rheumatology\/European League Against Rheumatism (ACR\/EULAR) classification criteria and is used extensively as a traditional biomarker in clinical practice. The study and findings of new autoantibodies in SjS has risen in the previous decade, with a central role given to diagnosis and elucidating new aspects of SjS physiopathology, while raising the opportunity to establish clinical phenotypes with the goal of predicting long-term complications. In this paper, we critically review the classic and the novel autoantibodies in SjS, analyzing the methods employed for detection, the pathogenic role and the wide spectrum of clinical phenotypes.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1003054","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T03:44:57Z","timestamp":1665978297000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sj\u00f6gren\u2019s syndrome: A critical review"],"prefix":"10.3389","volume":"13","author":[{"given":"Francisco","family":"V\u00edlchez-Oya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Balastegui Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Garc\u00eda-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e8ctor","family":"Corominas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.110","article-title":"Advances in understanding the pathogenesis of primary sj\u00f6gren's syndrome","volume":"9","author":"Nocturne","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.02.003","article-title":"Cytokine markers of b lymphocytes in minor salivary gland infiltrates in sj\u00f6gren's syndrome","volume":"17","author":"Navarro-Mendoza","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.07.003","article-title":"The role of ectopic germinal centers in the immunopathology of primary sj\u00f6gren's syndrome: A systematic review","volume":"42","author":"Risselada","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/art.11311","article-title":"Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with sj\u00f6gren's syndrome","volume":"48","author":"Salomonsson","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.05.006","article-title":"B-cell tolerance breakdown in sj\u00f6gren's syndrome: Focus on BAFF","volume":"9","author":"Varin","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.2.168","article-title":"The level of BLyS (BAFF) correlates with the titre of autoantibodies in human sj\u00f6gren's syndrome","volume":"62","author":"Mariette","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.09.003","article-title":"Novel autoantibodies in sj\u00f6gren's syndrome: A comprehensive review","volume":"18","author":"Mart\u00edn-Nares","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American college of Rheumatology\/European league against rheumatism classification criteria for primary sj\u00f6gren's syndrome: A consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214436","article-title":"Clinical relevance of HEp-2 indirect immunofluorescent patterns: The international consensus on ANA patterns (ICAP) perspective","volume":"78","author":"Damoiseaux","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.06.005","article-title":"Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay","volume":"10","author":"Op De Beeck","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2015-0887","article-title":"Added value of indirect immunofluorescence intensity of automated antinuclear antibody testing in a secondary hospital setting","volume":"54","author":"Oyaert","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00412","article-title":"Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015","volume":"6","author":"Chan","year":"2015","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.03.017","article-title":"Autoantibodies, detection methods and panels for diagnosis of Sj\u00f6gren's syndrome","volume":"182","author":"Shen","year":"2017","journal-title":"Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-0059-3","article-title":"Circulating auto-antibodies against nuclear and non-nuclear antigens in primary sj\u00f6gren's syndrome: Prevalence and clinical significance in 335 patients","volume":"25","author":"Nardi","year":"2006","journal-title":"Clin Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-004-0529-0","article-title":"The ro 60 kDa autoantigen: Insights into cellular function and role in autoimmunity","volume":"82","author":"Chen","year":"2004","journal-title":"J Mol Med (Berl)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2005.04.013","article-title":"Structural, functional and immunologic characterization of folded subdomains in the Ro52 protein targeted in sj\u00f6gren's syndrome","volume":"43","author":"Ottosson","year":"2006","journal-title":"Mol Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1014074107","article-title":"Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)","volume":"107","author":"Mallery","year":"2010","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/08916930400022954","article-title":"Anti-Ro\/SSA and La\/SSB antibodies","volume":"38","author":"Franceschini","year":"2005","journal-title":"Autoimmunity"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/32.6.449","article-title":"Detection of anti-Ro(SSA) antibodies in autoimmune diseases: Comparison of five methods","volume":"32","author":"Manoussakis","year":"1993","journal-title":"Br J Rheumatol"},{"key":"B21","article-title":"The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases: 1989-1992","volume":"10","author":"Charles","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-8949-","article-title":"Detection of SSA and SSB antibodies associated with primary sj\u00f6gren's syndrome using enzyme-linked immunosorbent assay","volume":"1901","author":"Trier","year":"2019","journal-title":"Methods Mol Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu439oa","article-title":"Simultaneous identification of various antinuclear antibodies using an automated multiparameter line immunoassay system","volume":"12","author":"L\u00f3pez-Longo","year":"2003","journal-title":"Lupus"},{"key":"B24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00005792-198103000-00002","article-title":"Serological findings in patients with \"ANA-negative\" systemic lupus erythematosus","volume":"60","author":"Maddison","year":"1981","journal-title":"Med (Baltimore)"},{"key":"B25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archderm.1988.01670010027017","article-title":"The relationship between anti-ro (SS-a) antibody-positive sj\u00f6gren's syndrome and anti-ro (SS-a) antibody-positive lupus erythematosus","volume":"124","author":"Provost","year":"1988","journal-title":"Arch Dermatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1177\/096120339700600211","article-title":"Cutaneous diseases in adults associated with anti-Ro\/SS-A autoantibody production","volume":"6","author":"McCauliffe","year":"1997","journal-title":"Lupus"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780360911","article-title":"Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A\/Ro and anti-SS-B\/La antibodies","volume":"36","author":"Buyon","year":"1993","journal-title":"Arthritis Rheum"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/0896-8411(88)90008-x","article-title":"Clinical implications of the presence of anti-ro (SSA) antibodies in patients with rheumatoid arthritis","volume":"1","author":"Skopouli","year":"1988","journal-title":"J Autoimmu"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198609113151103","article-title":"Maternal antibodies against fetal cardiac antigens in congenital complete heart block","volume":"315","author":"Taylor","year":"1986","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1136\/ard.61.5.398","article-title":"Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro\/SSA, La\/SSB and their linear epitopes in primary sj\u00f6gren's syndrome (pSS): A European multicentre study","volume":"61","author":"Tzioufas","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2012.05.022","article-title":"Autoantibodies in sj\u00f6gren's syndrome: Clinical presentation and regulatory mechanisms","volume":"41","author":"Tzioufas","year":"2012","journal-title":"Presse Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e318181e6af","article-title":"Primary sj\u00f6gren syndrome in Spain: Clinical and immunologic expression in 1010 patients","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Med (Baltimore)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1989.tb03446.x","article-title":"Function of the mammalian la protein: Evidence for its action in transcription termination by RNA polymerase III","volume":"8","author":"Gottlieb","year":"1989","journal-title":"EMBO J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206683","article-title":"The SSB-positive\/SSA-negative antibody profile is not associated with key phenotypic features of sj\u00f6gren's syndrome","volume":"74","author":"Baer","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-98-2-155","article-title":"Sj\u00f6gren's syndrome: Association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity","volume":"98","author":"Alexander","year":"1983","journal-title":"Ann Intern Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198905253202104","article-title":"Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis","volume":"320","author":"Van de Water","year":"1989","journal-title":"N Engl J Me"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jaut.2012.03.001","article-title":"Subgroups of Sj\u00f6gren syndrome patients according to serological profiles","volume":"39","author":"Bournia","year":"2012","journal-title":"J Autoimmun"},{"key":"B39","article-title":"Prevalence and longterm course of primary biliary cirrhosis in primary sj\u00f6gren's syndrome","volume":"35","author":"Hatzis","year":"2008","journal-title":"J Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2002.01165.x","article-title":"Do autoantibodies predict autoimmune liver disease in primary sj\u00f6gren's syndrome? Data of 180 patients upon a 5 year follow-up","volume":"56","author":"Csepregi","year":"2002","journal-title":"Scand J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2006.01292.x","article-title":"Sj\u00f6gren's syndrome: Why autoimmune epithelitis","volume":"12","author":"Mitsias","year":"2006","journal-title":"Oral Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100402","article-title":"Anticentromere-a and anticentromere-b antibodies show high concordance and similar clinical associations in patients with systemic sclerosis","volume":"37","author":"Hanke","year":"2010","journal-title":"J Rheumatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/s1542-3565(04)00465-3","article-title":"Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure","volume":"2","author":"Yang","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00296-004-0568-4","article-title":"Anti-CENP-H antibodies in patients with sjogren's syndrome","volume":"26","author":"Hsu","year":"2006","journal-title":"Rheumatol Int"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/s0009-8981(02)00419-9","article-title":"Antibodies to centromere antigens measured by an automated enzyme immunoassay","volume":"328","author":"Gonz\u00e1lez-Buitrago","year":"2003","journal-title":"Clin Chim Acta"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.046003","article-title":"Distinct recognition of antibodies to centromere proteins in primary sjogren's syndrome compared with limited scleroderma","volume":"65","author":"Gelber","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"B47","article-title":"Anticentromere antibodies identify patients with sj\u00f6gren's syndrome and autoimmune overlap syndrome","volume":"34","author":"Salliot","year":"2007","journal-title":"J Rheumatol"},{"key":"B48","article-title":"Clinical and laboratory features of anticentromere antibody positive primary sj\u00f6gren's syndrome","volume":"28","author":"Katano","year":"2001","journal-title":"J Rheumatol"},{"key":"B49","article-title":"Sj\u00f6gren's syndrome with anticentromere antibodies","volume":"64","author":"Caramaschi","year":"1997","journal-title":"Rev Rhum Engl Ed"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-015-3396-9","article-title":"Nailfold capillaroscopic findings in primary sj\u00f6gren's syndrome with and without raynaud's phenomenon and\/or positive anti-SSA\/Ro and anti-SSB\/La antibodies","volume":"36","author":"Corominas","year":"2016","journal-title":"Rheumatol Int"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2005.12.004","article-title":"Atypical autoantibodies in patients with primary Sj\u00f6gren syndrome: Clinical characteristics and follow-up of 82 cases","volume":"35","author":"Ramos-Casals","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"B52","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1186\/ar3237","article-title":"Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis","volume":"13","author":"Kokkonen","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2017.1324909","article-title":"Systematic review and meta-analysis of the epidemiology of polyautoimmunity in sj\u00f6gren's syndrome (secondary sj\u00f6gren's syndrome) focusing on autoimmune rheumatic diseases","volume":"47","author":"Alani","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.019794","article-title":"Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary sj\u00f6gren's syndrome","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1186\/ar2420","article-title":"Anti-cyclic citrullinated peptide antibodies in primary sj\u00f6gren syndrome may be associated with non-erosive synovitis","volume":"10","author":"Atzeni","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"B56","article-title":"Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in sj\u00f6gren's syndrome","volume":"34","author":"Barcelos","year":"2009","journal-title":"Acta Reumatol Port"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2572-4","article-title":"Follow-up of primary sjogren's syndrome patients presenting positive anti-cyclic citrullinated peptides antibody","volume":"33","author":"Ryu","year":"2013","journal-title":"Rheumatol Int"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3175-3","article-title":"Polyarthritis in primary sj\u00f6gren's syndrome represents a distinct subset with less pronounced b cell proliferation a Dutch cohort with long-term follow-up","volume":"35","author":"ter Borg","year":"2016","journal-title":"Clin Rheumatol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq047","article-title":"Articular manifestations in primary sj\u00f6gren's syndrome: Clinical significance and prognosis of 188 patients","volume":"49","author":"Fauchais","year":"2010","journal-title":"Rheumatol (Oxford)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.029066","article-title":"Development of additional autoimmune diseases in a population of patients with primary sj\u00f6gren's syndrome","volume":"64","author":"Lazarus","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000066","article-title":"ACPA-positive primary sj\u00f6gren's syndrome: True primary or rheumatoid arthritis-associated sj\u00f6gren's syndrome","volume":"1","author":"Payet","year":"2015","journal-title":"RMD Open"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2018.1469164","article-title":"Anti-citrullinated protein antibodies and arthritis in sj\u00f6gren's syndrome: A systematic review and meta-analysis","volume":"48","author":"Molano-Gonz\u00e1lez","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2013.04.020","article-title":"The accuracy of the anti-\u03b1-fodrin antibody test for diagnosis of sj\u00f6gren's syndrome: A meta-analysis","volume":"46","author":"Hu","year":"2013","journal-title":"Clin Biochem"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel270","article-title":"Clinical and immunological characteristics of patients with sj\u00f6gren's syndrome in relation to alpha-fodrin antibodies","volume":"46","author":"Willeke","year":"2007","journal-title":"Rheumatol (Oxford)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"795","DOI":"10.55563\/clinexprheumatol\/gy6udz","article-title":"Clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sj\u00f6gren's syndrome","volume":"39","author":"Mona","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e0116744","DOI":"10.1371\/journal.pone.0116744","article-title":"Meta-analysis of anti-muscarinic receptor type 3 antibodies for the diagnosis of sj\u00f6gren syndrome","volume":"10","author":"Deng","year":"2015","journal-title":"PloS One"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2014.08.009","article-title":"Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary sjogren's syndrome","volume":"155","author":"Shen","year":"2014","journal-title":"Clin Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.clim.2017.12.008","article-title":"Investigation of autoantibodies to SP-1 in Chinese patients with primary sj\u00f6gren's syndrome","volume":"188","author":"Xuan","year":"2018","journal-title":"Clin Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7935451","article-title":"Clinical correlations of novel autoantibodies in patients with dry eye","volume":"2019","author":"Karakus","year":"2019","journal-title":"J Immunol Res"},{"key":"B70","article-title":"Carbonic anhydrase autoantibodies and sicca symptoms in primary sj\u00f6gren\u00b4s syndrome","volume":"30","author":"Pertovaara","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4081\/reumatismo.2015.839","article-title":"Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary sj\u00f6gren's syndrome: Findings in serum and minor salivary glands","volume":"67","author":"Alunno","year":"2015","journal-title":"Reumatismo"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22632","article-title":"Association of antibodies to interferon-inducible protein-16 with markers of more severe disease in primary sj\u00f6gren's syndrome","volume":"68","author":"Baer","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B73","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13075-015-0722-2","article-title":"Interferon gamma-inducible protein 16 in primary sj\u00f6gren's syndrome: A novel player in disease pathogenesis","volume":"17","author":"Alunno","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2016.1196676","article-title":"A re-evaluation of anti-NA-14 antibodies in patients with primary sj\u00f6gren's syndrome: Significant role of interferon-\u03b3 in the production of autoantibodies against NA-14","volume":"49","author":"Uomori","year":"2016","journal-title":"Autoimmunity"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14882","article-title":"Autoantibody to MDM2: A potential serological marker of primary sjogren's syndrome","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-017-8970-7","article-title":"Autoantibodies binding to stathmin-4: New marker for polyneuropathy in primary sj\u00f6gren's syndrome","volume":"65","author":"Duda","year":"2017","journal-title":"Immunol Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4031-4","article-title":"The prevalence and clinical significance of anti-PUF60 antibodies in patients with idiopathic inflammatory myopathy","volume":"37","author":"Zhang","year":"2018","journal-title":"Clin Rheumatol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207509","article-title":"PUF60: a prominent new target of the autoimmune response in dermatomyositis and sj\u00f6gren's syndrome","volume":"75","author":"Fiorentino","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1002\/art.38127","article-title":"Memory dysfunction in primary sj\u00f6gren's syndrome is associated with anti-NR2 antibodies","volume":"65","author":"Lauvsnes","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/art.38852","article-title":"Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the n-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary sj\u00f6gren's syndrome","volume":"66","author":"Lauvsnes","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10290-y","article-title":"Neurofilament light is a biomarker of brain involvement in lupus and primary sj\u00f6gren's syndrome","volume":"268","author":"Tjensvoll","year":"2021","journal-title":"J Neurol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/art.39497","article-title":"Brief report: Patients with primary sj\u00f6gren's syndrome who are positive for autoantibodies to tripartite motif-containing protein 38 show greater disease severity","volume":"68","author":"Wolska","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/art.40550","article-title":"Brief report: Anti-calponin 3 autoantibodies: A newly identified specificity in patients with sj\u00f6gren's syndrome","volume":"70","author":"Birnbaum","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B84","article-title":"Prevalence and significance of anti-saccharomyces cerevisiae antibodies in primary sj\u00f6gren's syndrome","volume":"112","author":"Alunno","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23107","article-title":"Relationship between neuromyelitis optica spectrum disorder and sj\u00f6gren's syndrome: Central nervous system extraglandular disease or unrelated, Co-occurring autoimmunity","volume":"69","author":"Birnbaum","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8786-x","article-title":"Detection of autoantibodies against aquaporin-5 in the sera of patients with primary sj\u00f6gren's syndrome","volume":"64","author":"Alam","year":"2016","journal-title":"Immunol Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex328","article-title":"Antibodies to aquaporins are frequent in patients with primary sj\u00f6gren's syndrome","volume":"56","author":"Tzartos","year":"2017","journal-title":"Rheumatol (Oxford)"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2016.1147404","article-title":"Insights from the ganglionic acetylcholine receptor autoantibodies in patients with sj\u00f6gren's syndrome","volume":"26","author":"Mukaino","year":"2016","journal-title":"Mod Rheumatol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.12659\/msm.895144","article-title":"Elevated plasma p-selectin autoantibodies in primary sj\u00f6gren syndrome patients with thrombocytopenia","volume":"21","author":"Hu","year":"2015","journal-title":"Med Sci Monit"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.2174\/0929866525666180320110135","article-title":"Identification of moesin as a novel autoantigen in patients with sj\u00f6gren's syndrome","volume":"25","author":"Zhang","year":"2018","journal-title":"Protein Pept Lett"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207751","article-title":"Antibodies against carbamylated proteins are present in primary sj\u00f6gren's syndrome and are associated with disease severity","volume":"75","author":"Bergum","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15613","article-title":"Investigation of three potential autoantibodies in sjogren's syndrome and associated MALT lymphoma","volume":"8","author":"Cui","year":"2017","journal-title":"Oncotarget"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390808","article-title":"Detection of autoantibodies to nucleolar transcription factor NOR 90\/hUBF in sera of patients with rheumatic diseases, by recombinant autoantigen-based assays","volume":"39","author":"Fujii","year":"1996","journal-title":"Arthritis Rheum"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa881","article-title":"Anti-NuMA antibodies: Clinical associations and significance in patients with primary sj\u00f6gren's syndrome or systemic lupus erythematosus","volume":"60","author":"Arcani","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-007-8003-8","article-title":"Sj\u00f6gren's syndrome\u2013study of autoantigens and autoantibodies","volume":"32","author":"Routsias","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-011-9553-3","article-title":"Active immunological profile is associated with systemic sj\u00f6gren's syndrome","volume":"31","author":"Martel","year":"2011","journal-title":"J Clin Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/antib5010002","article-title":"Autoantibodies in SLE: Specificities, isotypes and receptors","volume":"5","author":"Dema","year":"2016","journal-title":"Antibodies (Basel)"},{"key":"B98","doi-asserted-by":"publisher","first-page":"8229","DOI":"10.1038\/s41598-021-87366-w","article-title":"Clinical utility of ANA-ELISA vs ANA-immunofluorescence in connective tissue diseases","volume":"11","author":"Alsaed","year":"2021","journal-title":"Sci Rep"},{"key":"B99","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13075-017-1380-3","article-title":"Emerging technologies in autoantibody testing for rheumatic diseases","volume":"19","author":"Olsen","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/art.38038","article-title":"Interferon-\u03b1 induction and detection of anti-ro, anti-la, anti-sm, and anti-rnp autoantibodies by autoantigen microarray analysis in juvenile dermatomyositis","volume":"65","author":"Balboni","year":"2013","journal-title":"Arthritis Rheum"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1003054\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T03:45:10Z","timestamp":1665978310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1003054\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":100,"alternative-id":["10.3389\/fimmu.2022.1003054"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1003054","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]},"article-number":"1003054"}}